C196H180N10O21S — CID 161437056
2-[4-[4-[2-(furan-2-yl)-2-oxoethyl]benzoyl]phenyl]-1-(4-morpholin-4-ylphenyl)ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-2-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-4-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-thiophen-2-ylethyl)benzoyl]phenyl]ethanone;2-[4-[4-[2-(4-morpholin-4-ylphenyl)-2-oxoethyl]benzoyl]phenyl]-1-phenylethanone;2-[4-[4-[2-oxo-2-(1H-pyrazol-4-yl)ethyl]benzoyl]phenyl]-1-(4-piperidin-1-ylphenyl)ethanone (PubChem CID 161437056) has the molecular formula C196H180N10O21S and a molecular weight of 3043.71 g/mol. Its IUPAC name is 2-[4-[4-[2-(furan-2-yl)-2-oxoethyl]benzoyl]phenyl]-1-(4-morpholin-4-ylphenyl)ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-2-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-4-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-thiophen-2-ylethyl)benzoyl]phenyl]ethanone;2-[4-[4-[2-(4-morpholin-4-ylphenyl)-2-oxoethyl]benzoyl]phenyl]-1-phenylethanone;2-[4-[4-[2-oxo-2-(1H-pyrazol-4-yl)ethyl]benzoyl]phenyl]-1-(4-piperidin-1-ylphenyl)ethanone.
| Compound Name | 2-[4-[4-[2-(furan-2-yl)-2-oxoethyl]benzoyl]phenyl]-1-(4-morpholin-4-ylphenyl)ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-2-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-4-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-thiophen-2-ylethyl)benzoyl]phenyl]ethanone;2-[4-[4-[2-(4-morpholin-4-ylphenyl)-2-oxoethyl]benzoyl]phenyl]-1-phenylethanone;2-[4-[4-[2-oxo-2-(1H-pyrazol-4-yl)ethyl]benzoyl]phenyl]-1-(4-piperidin-1-ylphenyl)ethanone |
|---|---|
| PubChem CID | 161437056 |
| Molecular Formula | C196H180N10O21S |
| Molecular Weight | 3043.71 g/mol |
| Exact Mass | 3041.30 |
| IUPAC Name | 2-[4-[4-[2-(furan-2-yl)-2-oxoethyl]benzoyl]phenyl]-1-(4-morpholin-4-ylphenyl)ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-2-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-pyridin-4-ylethyl)benzoyl]phenyl]ethanone;1-[4-(4-methylpiperidin-1-yl)phenyl]-2-[4-[4-(2-oxo-2-thiophen-2-ylethyl)benzoyl]phenyl]ethanone;2-[4-[4-[2-(4-morpholin-4-ylphenyl)-2-oxoethyl]benzoyl]phenyl]-1-phenylethanone;2-[4-[4-[2-oxo-2-(1H-pyrazol-4-yl)ethyl]benzoyl]phenyl]-1-(4-piperidin-1-ylphenyl)ethanone |
| SMILES | CC1CCN(c2ccc(C(=O)Cc3ccc(C(=O)c4ccc(CC(=O)c5ccccn5)cc4)cc3)cc2)CC1.CC1CCN(c2ccc(C(=O)Cc3ccc(C(=O)c4ccc(CC(=O)c5cccs5)cc4)cc3)cc2)CC1.CC1CCN(c2ccc(C(=O)Cc3ccc(C(=O)c4ccc(CC(=O)c5ccncc5)cc4)cc3)cc2)CC1.O=C(Cc1ccc(C(=O)c2ccc(CC(=O)c3ccc(N4CCOCC4)cc3)cc2)cc1)c1ccccc1.O=C(Cc1ccc(C(=O)c2ccc(CC(=O)c3ccco3)cc2)cc1)c1ccc(N2CCOCC2)cc1.O=C(Cc1ccc(C(=O)c2ccc(CC(=O)c3cn[nH]c3)cc2)cc1)c1ccc(N2CCCCC2)cc1 |
| InChI | InChI=1S/2C34H32N2O3.C33H29NO4.C33H31NO3S.C31H29N3O3.C31H27NO5/c1-24-16-20-36(21-17-24)31-12-10-27(11-13-31)32(37)22-25-2-6-29(7-3-25)34(39)30-8-4-26(5-9-30)23-33(38)28-14-18-35-19-15-28;1-24-17-20-36(21-18-24)30-15-13-27(14-16-30)32(37)22-25-5-9-28(10-6-25)34(39)29-11-7-26(8-12-29)23-33(38)31-4-2-3-19-35-31;35-31(26-4-2-1-3-5-26)22-24-6-10-28(11-7-24)33(37)29-12-8-25(9-13-29)23-32(36)27-14-16-30(17-15-27)34-18-20-38-21-19-34;1-23-16-18-34(19-17-23)29-14-12-26(13-15-29)30(35)21-24-4-8-27(9-5-24)33(37)28-10-6-25(7-11-28)22-31(36)32-3-2-20-38-32;35-29(24-12-14-28(15-13-24)34-16-2-1-3-17-34)18-22-4-8-25(9-5-22)31(37)26-10-6-23(7-11-26)19-30(36)27-20-32-33-21-27;33-28(24-11-13-27(14-12-24)32-15-18-36-19-16-32)20-22-3-7-25(8-4-22)31(35)26-9-5-23(6-10-26)21-29(34)30-2-1-17-37-30/h2-15,18-19,24H,16-17,20-23H2,1H3;2-16,19,24H,17-18,20-23H2,1H3;1-17H,18-23H2;2-15,20,23H,16-19,21-22H2,1H3;4-15,20-21H,1-3,16-19H2,(H,32,33);1-14,17H,15-16,18-21H2 |
| InChIKey | VYUACLRBFQRJEU-UHFFFAOYSA-N |
| XLogP | 36.15 |
| TPSA | 412.76 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 54 |
| Heavy Atoms | 228 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3043.71 |
| LogP ≤ 5 | 36.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 31 |